chr5-5146285-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_139056.4(ADAMTS16):c.331G>T(p.Asp111Tyr) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_139056.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAMTS16 | NM_139056.4 | c.331G>T | p.Asp111Tyr | missense_variant | Exon 3 of 23 | ENST00000274181.7 | NP_620687.2 | |
ADAMTS16 | XM_047416874.1 | c.331G>T | p.Asp111Tyr | missense_variant | Exon 3 of 22 | XP_047272830.1 | ||
ADAMTS16 | XM_047416875.1 | c.331G>T | p.Asp111Tyr | missense_variant | Exon 3 of 20 | XP_047272831.1 | ||
ADAMTS16 | NR_136935.2 | n.469G>T | non_coding_transcript_exon_variant | Exon 3 of 22 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAMTS16 | ENST00000274181.7 | c.331G>T | p.Asp111Tyr | missense_variant | Exon 3 of 23 | 2 | NM_139056.4 | ENSP00000274181.7 | ||
ADAMTS16 | ENST00000511368.5 | c.331G>T | p.Asp111Tyr | missense_variant | Exon 3 of 11 | 1 | ENSP00000421631.1 | |||
ADAMTS16 | ENST00000433402.2 | n.331G>T | non_coding_transcript_exon_variant | Exon 3 of 20 | 1 | |||||
ENSG00000250866 | ENST00000514848.1 | n.221-3914C>A | intron_variant | Intron 1 of 1 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.331G>T (p.D111Y) alteration is located in exon 3 (coding exon 3) of the ADAMTS16 gene. This alteration results from a G to T substitution at nucleotide position 331, causing the aspartic acid (D) at amino acid position 111 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at